Bovine herpesvirus 1 (BHV-1), like other members of the alphaherpesvirus family, establishes latent infections in neurons (1, 2, 6, 15, 17, 18) . Following a primary infection, the virus persists in the neurons of sensory and autonomic nerve ganglia of infected cattle (1, 6, 15) . Spontaneous and sporadic reactivation of the virus occurs in latently infected animals, and interestingly, latent virus can be reactivated predictably from infected animals following the administration of glucocorticoids (2, 4, 7, 9, 17, 18) . The nature of the virus-cell interaction that results in initiation, maintenance, and reactivation of this latent infection is unknown.
Investigations into the molecular basis of BHV-1 latency by means of a rabbit latency model (14, 15) have shown that the BHV-1 genome is transcriptionally active in latently infected ganglionic neurons, with transcription restricted to a region approximately 1.16 kilobases in size (0.740 to 0.748 map units) within HindlIl fragment D (14; D. Rock, unpublished data) . DNA sequence analysis of this region reveals two major open reading frames within the approximate map positions of the latency-related (LR) RNA and a potential Pol II promoter in close proximity to the 5' terminus of the LR RNA (Rock, unpublished data) . While it seems reasonable to hypothesize a role for this LR gene in viral latency or viral reactivation or both, the functional significance of its expression in latently infected neurons is unknown.
Given the probable significance of this gene in some aspect of BHV-1 latent infection, it undoubtedly will be important to understand the mechanisms governing its expression in sensory neurons. We examined the transcriptional promoter activity of the LR gene in a variety of cell types, including primary rabbit sensory neurons. The LR promoter was an efficient promoter in primary cultures of sensory ganglionic neurons compared with the simian virus 40 (SV40) early promoter-enhancer. In sharp contrast, the SV40 early pro-moter-enhancer was a better promoter in all other cells tested. Our results indicate that the LR promoter has strict orientation preferences in all cell types tested and that in bovine cells, promoter activity is stimulated by infection with BHV-1. A 146-base-pair (bp) XhoI fragment in the LR promoter functioned as a "silencer" in two different bovine cell lines. However, in monkey or rodent cells, the XhoI fragment enhanced promoter activity. A synthetic glucocorticoid, dexamethasone (DEX), regulated LR promoter activity in a negative fashion. Taken together, these results indicate that the LR gene of BHV-1 is regulated by tissueand species-specific transcription factors as well as viral or virus-induced factors.
MATERIALS AND METHODS Cells and viruses. Bovine lung and bovine turbinate cells were used throughout the experiments and maintained as described previously (16) . The Cooper strain of BHV-1, obtained from the National Veterinary Services Laboratory, Animal and Plant Health Inspection Service, Ames, Iowa, was used at passage 10. In infection experiments, bovine cell cultures or primary rabbit sensory neurons were infected with BHV-1 at a multiplicity of infection (MOI) of 10 either 5 or 18 h prior to harvest. Cell lines CV-1 (monkey fibroblasts), Rat-2 (rat fibroblasts), and JB-6 (mouse epithelial cells) were maintained as described previously (8) . The JB-6 cell line, C141, was obtained from Nancy Colburn (National Cancer Institute).
Nerve Construction of BHV-CAT plasmids. The plasmid pSV2cat contains the SV40 early promoter and enhancer 5' to the bacterial gene encoding CAT (5, 10) . Plasmid pSVOcat is a promoter-enhancer-minus CAT plasmid which contains unique HindIII and BamHI restriction enzyme sites 5' and 3', respectively, to the CAT gene. These plasmids were obtained from Bruce Howard (National Institutes of Health).
The 981-bp PstI fragment containing the 5' terminus of the LR gene ( Fig. 1 ) was cloned into pUC18 such that nucleotide 1 of the viral fragment was proximal to the unique HindIII site in the polylinker of pUC18. The plasmid was linearized by digestion with SmaI, and subsequently synthetic Hindlll linkers were added to the unique SmaI site in the polylinker region. Thus the 981-bp viral fragment could be released by HindIII digestion and contained 21 nucleotides of pUC18 polylinker from the SmaI site to nucleotide 981 of the viral PstI fragment. The 981-bp BHV-1 fragment, the LR promoter region, was inserted at the 5' terminus of pSVOcat (pO.9Scat/1 and pO.95cat/6; Fig. 2 ). The orientations of pO.95cat/1 and pO.95cat/6 were deduced by Sall-BamHI digestion and SphI-BamHI digestion. Plasmid pO.95cat/1 was digested with XhoI to release the 146-bp XhoI fragment from the LR promoter, and the vector plus BHV-1 fragment was recircularized (pAXho/1). Because of the presence of an XbaI site in the polylinker region of pUC-18, XbaI digestion of pO.95cat/1 released a 458-bp fragment of the LR promoter. orientations of pO.5Xba/47 and pO.5Xba/46 were deduced by SphI-BamHI digestion. The mouse mammary tumor virus long terminal repeat was obtained from plasmid pMAMneo (11) . After the addition of synthetic HindIlI linkers in the multiple cloning site of pMAMneo at the SmaI site, the mouse mammary tumor virus long terminal repeat was cloned into the unique HindlIl site of pSVOcat in the proper orientation to produce pMMTVcat/4. The orientation of pMMTVcat was deduced by double digestion with SaclBamHI. RESULTS cis activation of CAT gene by BHV-1 LR sequences. To examine the transcriptional promoter activity of the LR gene, a 981-bp PstI fragment (LR promoter) which contains the 5' terminus of the LR transcript was inserted adjacent to a promoter-minus CAT plasmid, pSVOcat, and promoter activity was examined in two bovine cell lines. The two bovine cell lines used in these studies were bovine lung and bovine turbinate. For simplicity, we present the data obtained from bovine turbinate cells; however, identical results were obtained with bovine lung cells (data not shown). The LR promoter region was active only if oriented so the 5' sequences of the LR transcript were adjacent to the CATcoding sequences of pO.95cat/1 (Fig. 2) . A plasmid, pO.95cat/ 6, which contains the 981-bp PstI fragment in the opposite orientation had little or no promoter activity. Removal of a 146-bp XhoI fragment from the LR promoter, pAXho/l, stimulated promoter activity at least sixfold with respect to pO.95cat/1. Furthermore, pAXho/1 had levels of promoter activity equivalent to those of the SV40 early promoterenhancer, pSV2cat. The individual XbaI fragments of the 981-bp fragment (pO.5Xba/47, pO.5Xba/46, and pO.95zXXba/4) had only basal promoter activity in transfected bovine cells. As expected, the promoter-minus vector, pSVOcat, displayed no promoter activity in bovine cells. These results suggest that the LR promoter was an orientation-dependent transcriptional promoter which contained an element, the XhoI region, that functioned as a silencer in bovine cells. Furthermore, the XbaI site of the LR promoter spans a critical region, since the individual XbaI fragments were not efficient promoters in bovine cells.
To assess the role lytic virus replication has on LR promoter activity, the various LR promoter constructs were transfected into bovine cells and subsequently infected with BHV-1 (MOI, 10) for 5 or 18 h prior to harvest. The promoter activity of pO.9Scat/l was clearly stimulated after viral infection (Fig. 2) . Promoter activity was more than eightfold higher in cells infected for 18 h than in uninfected cells. The orientations of the LR promoter sequences were also critical for transactivation after BHV-1 infection, since pO.95cat/6 had no promoter activity in uninfected or infected bovine cells. The promoter activity of pAXho/1 did not achieve the high level of pO.95cat/1 at 18 h postinfection. As expected, little if any promoter activity was detected in cells (normal or infected) transfected with a promoter-enhancerminus CAT plasmid, pSVOcat. In three independent experiments, the activity of the SV40 early promoter-enhancer, pSV2cat, was increased slightly in bovine cells infected with BHV-1. In contrast, infection of monkey cells (CV-1) by human herpes simplex virus 2 reduced pSV2cat promoter activity at late times during the lytic infection cycle (C. Jones, unpublished data). These results indicate LR promoter activity was enhanced by viral infection, and they further imply that the XhoI region of the LR promoter plays a role in efficient transactivation after BHV-1 infection.
LR promoter activity in neurons. Since the LR transcript is the exclusive transcript in rabbit sensory neurons latently infected with BHV (14) , the LR promoter should function (10 ,ug) . At 40 h posttransfection, cells were harvested and CAT enzymatic activity was measured (15 ,ug of protein, 2 h, 37°C) as described in Materials and Methods. Lanes: A, pO.95cat/1; B, pO.95cat/1, infected for 18 h with BHV-1 (MOI, 10) prior to harvest of cells; C, pAXho/1; D, pAXho/1 infected for 18 h with BHV-1 (MOI, 10) prior to harvest; E, pSV2cat; F, pSV2cat infected for 18 h with BHV-1 (MOI, 10) prior to harvest. The level of acetylated CM (ac-CM) is expressed as a percentage of the total radioactivity present in the various forms of CM. efficiently in ganglionic sensory neurons. To assess LR promoter activity in cultured rabbit sensory neurons, cells were transfected with the various CAT constructs, and at 40 h posttransfection, levels of CAT activity were measured. The 981-bp PstI fragment (pO.9Scat/1) was >10 times more efficient as a promoter in neurons than was the SV40 early promoter-enhancer (pSV2cat; Fig. 3 ). As in bovine cells, the orientation of the 981-bp fragment (pO.95cat/6) was crucial for promoter activity. Removal of the XhoI region from the LR promoter (pAXho/1) consistently had a slight negative effect on promoter activity. The individual XbaI fragments (pO.5Xba/47, pO.5Xba/46, and pO.95AXba/4) had no promoter activity in neurons. Taken together, the results indicate that in neurons, the LR promoter cis activated the CAT gene more efficiently than the SV40 early promoter-enhancer did. Furthermore, the XhoI region did not silence promoter activity in neurons as it did in bovine cells.
To test the effect viral infection had on promoter activity, neurons were transfected with the various promoter constructs and subsequently infected with BHV-1 18 h prior to measurement of CAT activity. The results indicate that infection had little effect on LR promoter activity (pO.95cat/1 and pAXho/1; Fig. 4 ). Infection of neurons by BHV-1 also had little effect on the promoter activity of the individual XbaI fragments (pO.5Xba/47, pO.5Xba/46, and pO.95AXba/4; data not shown). Thus, in sharp contrast to results from bovine cells, LR promoter activity was not stimulated by the infection of neurons with BHV-1.
LR promoter activity in primate and rodent cells. Promoter activity of the various LR promoter constructs in other mammalian cell lines was measured to compare it with that observed in bovine cells. The results of these experiments in three cell lines (CV-1, Rat-2, and JB-6) are presented in Table 1 . As in bovine cells, (i) pO.95cat/1 had substantial VOL. 64, 1990 pO.5Xba/47 b Restriction enzyme sites: P, PstI; X, Xhol; S, SphI; Xb, XbaI.
Results are the averages of three independent experiments (bovine cells, CV-1, and Rat-2) or two experiments (JB-6) ± standard deviation.
promoter activity that was significantly lower than the promoter activity of pSV2cat; (ii) if the orientation of the BHV-1 insert was opposite that of pO.95cat/1 (pO.95cat/6), no promoter activity was observed; (iii) the individual XbaI fragments, pO.5Xba/47 and pO.95AXba/4, also had little or no promoter activity. In sharp contrast to the situation in bovine cells, removal of the 146-bp XhoI fragment had a slight but reproducible negative effect on promoter activity in the cell lines tested. These results indicate that the BHV-1 LR promoter functioned in a variety of nonbovine cell lines and also imply that a bovine-specific factor(s) regulated this viral promoter. Effect of DEX on promoter activity. DEX treatment of animals latently infected with BHV-1 leads to reactivation of the virus and a transient decrease in the number of LR RNA-containing neurons present in ganglia (4, 9, 17; Rock,  unpublished data). Thus, DEX may induce reactivation or reduce the expression of the LR gene. To test the effect DEX has on the LR promoter, bovine cells were transfected with the designated plasmids, and promoter activity in cells treated with DEX and in untreated cells was measured. DEX treatment consistently led to a reduction of promoter activity in cells transfected with pO.95cat/1 or pAXho/1 (Fig. 5) . Like Mordacq and Linzer (13) , we observed that DEX treatment of mammalian cells decreased promoter activity of the SV40 early promoter-enhancer (data not shown). In sharp contrast to these results, the mouse mammary tumor virus long terminal repeat-CAT construct (pMMTV-4) was stimulated more than 10-fold by DEX treatment ( Fig. 5; 11 ). DEX treatment of bovine cells downregulated the LR promoter and could thus conceivably play a role during the latent infection cycle. DISCUSSION We have identified and characterized the transcriptional promoter which regulates the expression of the LR transcript of BHV-1. The LR promoter contains a 146-bp element, the XhoI region, which silences promoter activity in bovine cells and seemingly prevents the efficient expression of the LR transcript until late in the lytic infection cycle. This same XhoI region seems to have a modest enhancing function in ganglionic sensory neurons, rodent cells, and monkey cells. In essence, the LR promoter is a complex yet diverse transcriptional promoter element which apparently is regulated by tissue-specific or species-specific transcription factors.
In bovine cells, the LR promoter was efficiently transactivated by BHV-1 infection (Fig. 2) infection when compared with pO.95cat/1. The XhoI region not only was involved with transactivation of promoter activity by BHV-1 infection but, more important, functioned as a negative regulatory element in bovine cells. This may imply that bovine-specific factors are involved with regulating LR promoter activity.
The LR promoter was an extremely efficient promoter in sensory ganglionic neurons when compared with the SV40 early promoter-enhancer ( Fig. 3 and 4) . The LR promoter had at least 10-times-higher promoter activity than pSV2cat did in neurons. In contrast, pSV2cat was six-to eightfold more active in bovine, rodent, or monkey cells (Fig. 2, Table  1 ). This implies that cellular factors present in neurons can efficiently activate the LR promoter. Another possibility, which cannot be ruled out, is that neurons possess factors which specifically block some promoters, such as the SV40 early promoter-enhancer. In contrast to the results observed in bovine cells, promoter activity in neurons was slightly repressed by removal of the XhoI region. This seems to support the notion that species-and tissue-specific factors regulate, in part, LR promoter activity. As in bovine cells, the individual XbaI fragments had little or no promoter activity. Quite surprisingly, infection of neurons by BHV-1 had little effect on LR promoter activity. Perhaps infection of cultured neurons was an inefficient process, and thus few cells were infected. However, these results clearly indicate that the LR promoter was an efficient promoter in neurons and thus explain, in part, the efficient expression of the LR transcript during latent infection of neurons by BHV-1. It should prove quite interesting to examine the interplay of cellular and viral factors with the LR promoter regulatory region and ultimately to determine how these factors regulate expression of the LR transcript.
The fact that a synthetic glucocorticoid, DEX, had a profound negative effect on LR promoter activity is particularly interesting given its ability to induce viral reactivation in latently infected animals (4, 9, 16, 17) . This in vitro finding is in good agreement with studies that examined the early ganglionic events surrounding DEX-induced BHV-1 reactivation. Previous studies demonstrated that the number of neurons expressing LR RNA in latently infected ganglia decreased significantly (60%) 24 to 48 h posttreatment, with a return to control values by 72 h posttreatment. (Rock et al., unpublished data). Considering the negative effect DEX has on LR promoter activity, the transient decrease in LR RNA-containing ganglionic neurons is best explained as downregulation of LR RNA expression in these cells. The positive correlation of latent viral reactivation with this decrease makes it tempting to speculate that altered regulation of LR RNA transcription is a significant event in latent viral reactivation. 
